Trgovina Context Therapeutics Inc. - CNTX CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Pogoji trgovanja
| Razmik | 0.44 | ||||||||
|
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.025457% | ||||||||
|
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.003235% | ||||||||
| Čas nočne pristojbine | 21:00 (UTC) | ||||||||
| Min. tržena količina | 1 | ||||||||
| Valuta | USD | ||||||||
| Kritje | 20% | ||||||||
| Borza | United States of America | ||||||||
| Provizija na trgovanje | 0% |
*Information provided by Capital.com
Ključni statistični podatki
| Predhodno. Zapri* | N/A |
| Odpri* | N/A |
| Enoletna sprememba* | N/A |
| Dnevni razpon* | N/A |
| Razpon 52 wk | 0.47-2.52 |
| Povprečni obseg (10 dni) | 253.28K |
| Povprečni obseg (3 meseci) | 2.56M |
| Tržna kapitalizacija | 14.05M |
| Razmerje P/E | -100.00K |
| Število delnic v obtoku | 15.97M |
| Prihodki | N/A |
| EPS | -1.11 |
| Dividenda (donosnost v %) | N/A |
| Beta | -100.00K |
| Datum naslednjega zaslužka | N/A |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
|---|---|---|---|---|---|---|
| Jun 27, 2022 | 2.02 | 0.00 | 0.00% | 2.02 | 2.02 | 2.02 |
| May 24, 2022 | 1.76 | 0.01 | 0.57% | 1.75 | 1.76 | 1.75 |
| May 23, 2022 | 1.55 | 0.01 | 0.65% | 1.54 | 1.55 | 1.54 |
| Apr 19, 2022 | 1.53 | 0.02 | 1.32% | 1.51 | 1.54 | 1.48 |
| Apr 5, 2022 | 2.22 | -0.01 | -0.45% | 2.23 | 2.23 | 2.22 |
| Mar 28, 2022 | 1.86 | 0.05 | 2.76% | 1.81 | 1.86 | 1.81 |
| Feb 24, 2022 | 1.61 | 0.00 | 0.00% | 1.61 | 1.61 | 1.61 |
| Feb 11, 2022 | 1.93 | -0.11 | -5.39% | 2.04 | 2.09 | 1.92 |
| Feb 10, 2022 | 2.06 | 0.02 | 0.98% | 2.04 | 2.16 | 2.02 |
| Feb 9, 2022 | 2.13 | 0.15 | 7.58% | 1.98 | 2.14 | 1.98 |
| Feb 8, 2022 | 1.98 | -0.02 | -1.00% | 2.00 | 2.01 | 1.90 |
| Feb 7, 2022 | 2.04 | -0.09 | -4.23% | 2.13 | 2.20 | 2.03 |
| Feb 4, 2022 | 2.17 | 0.02 | 0.93% | 2.15 | 2.21 | 2.09 |
| Feb 3, 2022 | 2.19 | -0.03 | -1.35% | 2.22 | 2.25 | 2.15 |
| Feb 2, 2022 | 2.29 | 0.12 | 5.53% | 2.17 | 2.39 | 2.15 |
| Feb 1, 2022 | 2.11 | 0.14 | 7.11% | 1.97 | 2.13 | 1.97 |
| Jan 31, 2022 | 2.01 | 0.10 | 5.24% | 1.91 | 2.07 | 1.91 |
| Jan 28, 2022 | 1.91 | 0.01 | 0.53% | 1.90 | 1.96 | 1.84 |
| Jan 27, 2022 | 1.92 | -0.17 | -8.13% | 2.09 | 2.09 | 1.91 |
| Jan 26, 2022 | 2.07 | -0.14 | -6.33% | 2.21 | 2.25 | 2.00 |
Context Therapeutics Inc. Events
| Čas (UTC) (UTC) | Država | Dogodek |
|---|---|---|
| No events scheduled | ||
- Letni
- Četrtletno
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Skupni prihodki | 0 | 0 | 0 | 0 |
| Celotni odhodki iz poslovanja | 15.3812 | 10.4258 | 2.57217 | 5.37714 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 7.79004 | 3.63292 | 0.93067 | 2.96521 |
| Raziskave in razvoj | 7.59116 | 6.8929 | 1.6415 | 2.41194 |
| Prihodki iz poslovanja | -15.3812 | -10.4258 | -2.57217 | -5.37714 |
| Prihodki (odhodki) od obresti, neto Neoperativni | 0.54727 | -0.05492 | 9.21664 | -1.00702 |
| Čisti dobiček pred obdavčitvijo | -14.8359 | -10.4569 | 6.64447 | -6.38417 |
| Čisti dobiček po davkih | -14.8359 | -10.4569 | 6.64447 | -6.38417 |
| Čisti dobiček pred dodatnimi postavkami | -14.8359 | -10.4569 | 6.64447 | -6.38417 |
| Čisti dobiček | -14.8359 | -10.4569 | 6.64447 | -6.38417 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -14.8359 | -10.4569 | 6.64447 | -6.38417 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -14.8359 | -10.4569 | 6.64447 | -6.38417 |
| Popravljen čisti dobiček | -14.8359 | -10.4569 | 6.64447 | -6.38417 |
| Popravljene ponderirane povprečne delnice | 15.9661 | 15.9827 | 10.9598 | 6.87672 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.92922 | -0.65426 | 0.60626 | -0.92837 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | ||
| Popravljen normalizirani dobiček na enoto čistega dobička | -0.92922 | -0.66052 | 0.60626 | -0.92837 |
| Nenavadni odhodki (prihodki) | -0.1 | |||
| Drugo, neto | -0.002 | 0.02387 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Skupni prihodki | 0 | 0 | 0 | 0 | 0 |
| Celotni odhodki iz poslovanja | 6.66655 | 3.88234 | 4.04809 | 4.00781 | 3.44296 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 2.13187 | 1.73748 | 1.97052 | 1.99057 | 2.09147 |
| Raziskave in razvoj | 4.53468 | 2.14486 | 2.07757 | 2.01724 | 1.3515 |
| Prihodki iz poslovanja | -6.66655 | -3.88234 | -4.04809 | -4.00781 | -3.44296 |
| Prihodki (odhodki) od obresti, neto Neoperativni | 0.35554 | 0.32786 | 0.19225 | 0.0213 | 0.00586 |
| Drugo, neto | 0.00269 | -0.0023 | 0.00153 | 0 | -0.00124 |
| Čisti dobiček pred obdavčitvijo | -6.30832 | -3.55678 | -3.85431 | -3.98651 | -3.43834 |
| Čisti dobiček po davkih | -6.30832 | -3.55678 | -3.85431 | -3.98651 | -3.43834 |
| Čisti dobiček pred dodatnimi postavkami | -6.30832 | -3.55678 | -3.85431 | -3.98651 | -3.43834 |
| Čisti dobiček | -6.30832 | -3.55678 | -3.85431 | -3.98651 | -3.43834 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -6.30832 | -3.55678 | -3.85431 | -3.98651 | -3.43834 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -6.30832 | -3.55678 | -3.85431 | -3.98651 | -3.43834 |
| Popravljen čisti dobiček | -6.30832 | -3.55678 | -3.85431 | -3.98651 | -3.43834 |
| Popravljene ponderirane povprečne delnice | 15.9661 | 15.9661 | 15.9661 | 15.9661 | 15.9661 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.39511 | -0.22277 | -0.24141 | -0.24969 | -0.21535 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Popravljen normalizirani dobiček na enoto čistega dobička | -0.39511 | -0.22277 | -0.24141 | -0.24969 | -0.21535 |
| Nenavadni odhodki (prihodki) |
- Letni
- Četrtletno
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 37.8537 | 51.2554 | 0.34971 | 0.23961 |
| Denarna sredstva in kratkoročne naložbe | 35.4975 | 49.6352 | 0.34104 | 0.2266 |
| Denarna sredstva in ustrezniki | 35.4975 | 49.6352 | 0.34104 | 0.2266 |
| Prepaid Expenses | 2.35621 | 1.62016 | 0.00867 | 0.013 |
| Total Assets | 37.9659 | 51.3058 | 0.46734 | 0.27355 |
| Other Long Term Assets, Total | 0.03275 | 0.05039 | 0.11763 | 0.03394 |
| Total Current Liabilities | 3.20758 | 3.03342 | 9.54816 | 24.1083 |
| Accounts Payable | 0.93633 | 1.82629 | 2.70786 | 2.0679 |
| Accrued Expenses | 2.18779 | 1.20712 | 0.95599 | 0.19747 |
| Notes Payable/Short Term Debt | 0 | 0 | 5.82929 | 21.8429 |
| Current Port. of LT Debt/Capital Leases | 0 | 0.05501 | 0 | |
| Total Liabilities | 3.20758 | 3.03342 | 9.6172 | 24.1083 |
| Total Long Term Debt | 0 | 0 | 0.06904 | 0 |
| Long Term Debt | 0 | 0.06904 | 0 | |
| Total Equity | 34.7584 | 48.2723 | -9.14986 | -23.8348 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 7.74222 | 0 |
| Common Stock | 0.01597 | 0.01597 | 0.02903 | 0.12603 |
| Additional Paid-In Capital | 78.8328 | 77.5108 | 1.87646 | 1.48125 |
| Retained Earnings (Accumulated Deficit) | -44.0904 | -29.2544 | -18.7976 | -25.442 |
| Total Liabilities & Shareholders’ Equity | 37.9659 | 51.3058 | 0.46734 | 0.27355 |
| Total Common Shares Outstanding | 15.9661 | 15.9827 | 10.9598 | 6.87672 |
| Property/Plant/Equipment, Total - Net | 0.07954 | |||
| Other Current Liabilities, Total | 0.08346 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 31.8857 | 37.8537 | 41.9392 | 44.4998 | 46.8573 |
| Denarna sredstva in kratkoročne naložbe | 29.769 | 35.4975 | 39.4271 | 42.9212 | 45.7282 |
| Denarna sredstva in ustrezniki | 29.769 | 35.4975 | 39.4271 | 42.9212 | 45.7282 |
| Prepaid Expenses | 2.11674 | 2.35621 | 2.51208 | 1.57862 | 1.12911 |
| Total Assets | 31.9662 | 37.9659 | 42.083 | 44.6968 | 47.0328 |
| Other Long Term Assets, Total | 0.02619 | 0.03275 | 0.03931 | 0.06775 | 0.024 |
| Total Current Liabilities | 3.23337 | 3.20758 | 4.01151 | 3.03953 | 1.60666 |
| Accounts Payable | 1.21026 | 0.93633 | 1.495 | 0.94546 | 0.45483 |
| Accrued Expenses | 1.97886 | 2.18779 | 2.45623 | 2.09407 | 1.15182 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | |||||
| Total Liabilities | 3.23337 | 3.20758 | 4.01151 | 3.04749 | 1.63833 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Long Term Debt | |||||
| Total Equity | 28.7328 | 34.7584 | 38.0715 | 41.6493 | 45.3945 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 0.01597 | 0.01597 | 0.01597 | 0.01597 | 0.01597 |
| Additional Paid-In Capital | 79.1155 | 78.8328 | 78.5891 | 78.3126 | 78.0713 |
| Retained Earnings (Accumulated Deficit) | -50.3987 | -44.0904 | -40.5336 | -36.6793 | -32.6928 |
| Total Liabilities & Shareholders’ Equity | 31.9662 | 37.9659 | 42.083 | 44.6968 | 47.0328 |
| Total Common Shares Outstanding | 15.9661 | 15.9661 | 15.9661 | 15.9661 | 15.9661 |
| Property/Plant/Equipment, Total - Net | 0.05427 | 0.07954 | 0.10451 | 0.12921 | 0.15147 |
| Other Liabilities, Total | 0.00797 | 0.03167 | |||
| Other Current Liabilities, Total | 0.04425 | 0.08346 | 0.06029 |
- Letni
- Četrtletno
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Čisti prihodki/začetna postavka | -14.8359 | -10.4569 | 6.64447 | -6.38417 |
| Denarna sredstva iz poslovanja | -13.5492 | -8.79949 | -1.03462 | -2.8361 |
| Nedenarne postavke | 1.55496 | 3.88223 | -8.99739 | 2.98628 |
| Spremembe v obratnem kapitalu | -0.27752 | -2.22484 | 1.3183 | 0.56179 |
| Denarna sredstva pri financiranju | -0.10207 | 58.394 | 1.14905 | 1.95741 |
| Izdaja (odplačilo) delnic, neto | 0 | 58.394 | 1 | 0 |
| Izdaja (odplačilo) dolga, neto | 0 | 0.14905 | 1.95741 | |
| Neto sprememba denarnih sredstev | -14.1881 | 49.3446 | 0.11443 | -0.87869 |
| Denarna sredstva pri naložbenju | -0.53684 | -0.25 | ||
| Celotne druge postavke denarnih tokov pri naložbenju | -0.5 | -0.25 | ||
| Denarna sredstva iz poslovanja | 0.00927 | |||
| Kapitalski izdatki | -0.03684 | |||
| Postavke denarnega toka pri financiranju | -0.10207 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -6.30832 | -14.8359 | -11.2792 | -7.42485 | -3.43834 |
| Cash From Operating Activities | -5.72846 | -13.5492 | -9.61956 | -6.62547 | -3.82028 |
| Non-Cash Items | 0.30484 | 1.55496 | 1.28954 | 0.99152 | 0.22898 |
| Changes in Working Capital | 0.27183 | -0.27752 | 0.36398 | -0.19502 | -0.61092 |
| Cash From Financing Activities | 0 | -0.10207 | -0.10207 | -0.10207 | -0.10207 |
| Issuance (Retirement) of Stock, Net | 0 | 0 | 0 | 0 | |
| Issuance (Retirement) of Debt, Net | |||||
| Net Change in Cash | -5.72846 | -14.1881 | -10.2585 | -6.76437 | -3.95735 |
| Cash From Investing Activities | 0 | -0.53684 | -0.53684 | -0.03684 | -0.035 |
| Other Investing Cash Flow Items, Total | -0.5 | -0.5 | 0 | ||
| Financing Cash Flow Items | 0 | -0.10207 | -0.10207 | -0.10207 | -0.10207 |
| Capital Expenditures | 0 | -0.03684 | -0.03684 | -0.03684 | -0.035 |
| Cash From Operating Activities | 0.00319 | 0.00927 | 0.00607 | 0.00288 |
| Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
|---|---|---|---|---|---|---|
| Lehr (Martin A) | Individual Investor | 6.1009 | 974068 | -5823 | 2023-03-01 | LOW |
| Sabby Management, LLC | Investment Advisor/Hedge Fund | 4.99 | 796706 | 796706 | 2022-12-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.5914 | 573400 | -67463 | 2023-03-31 | LOW |
| Clough Capital Partners, LP | Investment Advisor/Hedge Fund | 1.3923 | 222288 | 0 | 2023-03-31 | HIGH |
| swisspartners Ltd. | Investment Advisor | 1.1274 | 180000 | 95000 | 2022-12-31 | LOW |
| Hightower Advisors, LLC | Investment Advisor | 0.7882 | 125852 | 0 | 2023-03-31 | LOW |
| Bridgeway Capital Management, LLC | Investment Advisor | 0.6627 | 105809 | 0 | 2023-03-31 | LOW |
| Mill Creek Capital Advisors, LLC | Investment Advisor | 0.6553 | 104631 | 0 | 2023-03-31 | |
| Two Sigma Investments, LP | Hedge Fund | 0.4503 | 71888 | 26004 | 2023-03-31 | HIGH |
| Levit (Alex C.) | Individual Investor | 0.3882 | 61983 | 52933 | 2023-03-01 | HIGH |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.3731 | 59568 | -1634 | 2023-03-31 | LOW |
| Swisspartners Investment Network AG | Investment Advisor | 0.2645 | 42235 | 0 | 2022-06-30 | LOW |
| Virtu Americas LLC | Research Firm | 0.258 | 41191 | -16264 | 2023-03-31 | HIGH |
| Minai-azary (Jennifer Lynn) | Individual Investor | 0.2505 | 40000 | 0 | 2023-03-01 | MED |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.2331 | 37219 | 0 | 2023-03-31 | LOW |
| Difesa Capital Management, LP | Investment Advisor | 0.2185 | 34878 | 0 | 2023-03-31 | MED |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.2061 | 32907 | 0 | 2023-03-31 | LOW |
| Susquehanna International Group, LLP | Investment Advisor | 0.1541 | 24599 | 24599 | 2023-03-31 | MED |
| Sheets Smith Wealth Management | Investment Advisor | 0.1253 | 20000 | 20000 | 2023-03-31 | LOW |
| Renaissance Technologies LLC | Hedge Fund | 0.1203 | 19200 | -86100 | 2023-03-31 | HIGH |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group530K+
Borzni posredniki
87K+
Aktivne stranke mesečno
$46M+
Mesečni obseg naložb
$31M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
Trgovalna provizija
0
- 1:1
Vzvod
1:1
- 20
- 100
- 500
- 1000
- 10000
Naložbe
Velikost posla (finančni vzvod x naložba):
Odpiranje
Zapiranje
Kratka Dolga
Context Therapeutics Inc. Company profile
O družbi Context Therapeutics Inc.
Context Therapeutics Inc., prej Context Therapeutics LLC, je biofarmacevtsko podjetje v klinični fazi, ki se osredotoča na izboljšanje življenja žensk z rakom. Podjetje se ukvarja z razvojem zdravljenja z majhnimi molekulami in imunoterapije, da bi spremenilo oskrbo hormonsko pogojenega raka dojk in ginekološkega raka. Klinični program vodilnega kandidata, onapristona s podaljšanim sproščanjem (ONA-XR), obsega tri klinična preskušanja faze 2 in eno klinično preskušanje faze 1b/2 pri hormonsko pogojenem raku dojk, jajčnikov in endometrija ter dve farmakodinamični preskušanji faze 0 z biomarkerjem pri raku dojk. ONA-XR je majhna molekula v razvoju kot popolni antagonist progesteronskega receptorja, ključnega nekontroliranega mehanizma pri hormonsko pogojenem ženskem raku. Drugi program, CLDN6xCD3, je bispecifično monoklonsko protitelo anti-CD3 x anti-Claudin 6 (bsAbs), ki je namenjeno preusmerjanju lize, posredovane s celicami T, na maligne celice, ki izražajo Claudin 6 (CLDN6).
| Industry: | Biotechnology & Medical Research (NEC) |
2001 Market Street
Suite 3915 Unit #15
PHILADELPHIA
PENNSYLVANIA 19103
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 530.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com